2024 HCPCS Code Q0239
Injection, bamlanivimab-xxxx, 700 mg
| Notice | HCPCS Q0239 terminated on April 16, 2021. |
| Short Description | Bamlanivimab-xxxx |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | April 17, 2021 |
| HCPCS Code Added Date | November 09, 2020 |
| HCPCS Pricing Indicator Code | 54 - Vaccinations |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | V - Pneumococcal/flu vaccine (eff 01/96), Pneumococcal/flu/hepatitis B vaccine (eff 04/95-12/95), Pneumococcal only before 04/95 |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- Q0139 - Ferumoxytol, esrd use
- Q0144 - Azithromycin dihydrate, oral
- Q0161 - Chlorpromazine hcl 5mg oral
- Q0162 - Ondansetron oral
- Q0163 - Diphenhydramine hcl 50mg
- Q0164 - Prochlorperazine maleate 5mg
- Q0166 - Granisetron hcl 1 mg oral
- Q0167 - Dronabinol 2.5mg oral
- Q0169 - Promethazine hcl 12.5mg oral
- Q0173 - Trimethobenzamide hcl 250mg
- Q0174 - Thiethylperazine maleate10mg
- Q0175 - Perphenazine 4mg oral
- Q0177 - Hydroxyzine pamoate 25mg
- Q0180 - Dolasetron mesylate oral
- Q0181 - Unspecified oral anti-emetic
- Q0220 - Tixagev and cilgav, 300mg
- Q0221 - Tixagev and cilgav, 600mg
- Q0222 - Bebtelovimab 175 mg
- Q0224 - Inj, pemivibart, 4500 mg
- Q0239 - Bamlanivimab-xxxx